CEO Doug Murphy-Chutorian highlighted strong performance and cash generation from healthcare operations in 2024. He emphasized the company's focus on its Bitcoin treasury strategy, with Bitcoin now ...
Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal healthcare fraud claims related to its peripheral artery disease test, QuantaFlo — a product used by ...
Semler Scientific, Inc. is a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases. Its flagship product, QuantaFlo®, which is ...
Semler Scientific Inc. stock grades by Barron's. View SMLR fundamental and sentiment analysis powered by MarketGrader.
Semler Scientific will pay the Department of Justice nearly $30 million to settle health care fraud claims related to its peripheral artery disease test, QuantaFlo — a device used by UnitedHealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results